In vitro activity of curcumin in combination with epigallocatechin gallate (EGCG) versus multidrug-resistant Acinetobacter baumannii

BMC Microbiology

David W Wareham¹  Jonathan W Betts² 

[1] Division of Infection, Barts Health NHS Trust, London E1 2ES, UK;Antimicrobial Research Group, Centre for Immunology and Infectious Disease, Blizard Institute, Queen Mary University London, 4, Newark Street, Whitechapel, London E1 2AT, UK

关键词: Antibacterial;    Synergy;    Acinetobacter baumannii;    Epigallocatechin gallate;    Curcumin;   

Others  :  821253
DOI  :  10.1186/1471-2180-14-172

 received in 2014-04-23, accepted in 2014-06-19,  发布年份 2014

【 摘 要 】

Background

Acinetobacter baumannii is an opportunistic human pathogen often associated with life-threatening infections in the immunocompromised and the critically ill. Strains are often multidrug-resistant (MDR) and due to the lack of new synthetic antimicrobials in development for treatment, attention is increasingly focused on natural compounds either as stand-alone or adjunctive agents. Curcumin (CCM) is a natural polyphenol found in turmeric and isolated from the plant, Curcuma longa. Curcumin has been found to possess many biological properties, including antibacterial activity. In this study the antimicrobial activity of CCM and synergistic effects with epigallocatechin gallate (EGCG) against multidrug-resistant strains of A. baumannii were investigated and assessed via checkerboard and time-kill assays.

Results

The MIC of CCM was >256 μg/mL against all strains of A. baumannii whilst those for EGCG ranged from 128-1024 μg/mL. In checkerboard studies synergy was observed against 5/9 isolates, with an additive effect noted in the remaining 4. The addition of EGCG reduced the MIC of CCM by 3- to 7-fold, with the greatest interaction resulting in a CCM MIC of 4 μg/mL. Time-kill curves indicated that a CCM-EGCG (1:8 and 1:4) combination was bactericidal with a 4 to 5-log reduction in viable counts after 24 h compared to the most effective polyphenol alone.

Conclusions

This study demonstrates that despite little antibacterial activity alone, CCM activity is greatly enhanced in the presence of EGCG resulting in antibacterial activity against MDR A. baumannii. The combination may have a potential use in medicine as a topical agent to prevent or treat A. baumannii infections.

【 授权许可】

   
2014 Betts and Wareham; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Gordon NC, Png K, Wareham DW: Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii. Antimicrob Agents Chemother 2010, 54(12):5316-5322.
• [2]Peleg AY, Seifert H, Paterson DL: Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21(3):538-582.
• [3]Maheshwari RK, Singh AK, Gaddipati J, Srimal RC: Multiple biological activities of curcumin: A short review. Life Sci 2006, 78(18):2081-2087.
• [4]Hu P, Huang P, Chen MW: Curcumin reduces Streptococcus mutans biofilm formation by inhibiting sortase A activity. Arch Oral Biol 2013, 58:1343-1348.
• [5]De R, Kundu P, Swarnakar S, Ramamurthy T, Chowdhury A, Nair GB, Mukhopadyay AK: Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob Agents Chemother 2009, 53(4):1592-1597.
• [6]Mun AH, Joung DK, Kim YS, Kang OH, Kim SB, Seo YS, Kim YC, Lee DS, Shin DW, Kweon KT, Kwon DY: Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus. Phytomed 2013, 20:714-718.
• [7]Marathe SA, Kumar R, Ajitkumar P, Nagaraja V, Chakravortty D: Curcumin reduces the antimicrobial activity of ciprofloxacin against Salmonella typhi. J Antimicrob Chemother 2013, 68(1):139-152.
• [8]Gordon NC, Wareham DW: Antimicrobial activity of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) against clinical isolates of Stenotrophomonas maltophilia. Int J Antimicrob Agents 2010, 36(2):129-131.
• [9]Kono K, Tatara I, Takeda S, Arakawa K, Shirotani T, Okada M, Hara Y: Antibacterial activity of epigallocatechin gallate against Helicobacter pylori: Synergistic effect with Plaunotol. J Infect Chemothery 1997, 3:170-172.
• [10]Osterburg A, Gardner J, Hyon SH, Neely A, Babcock G: Highly antibiotic-resistant Acinetobacter baumannii clinical isolates are killed by the tea polyphenol (-)-epigallocatechin-3-gallate (EGCG). Clin Microbiol Infect 2009, 15:341-346.
• [11]Zhao WH, Hu ZQ, Hara Y, Shimamura T: Inhibition of penicillinase by epigallocatechin gallate resulting in restoration of antibacterial activity of penicillin against penicillinase-producing staphylococcus aureus. Antimicrob Agents Chemother 2002, 46(7):2266-2268.
• [12]Betts JW, Kelly SM, Haswell SJ: Antibacterial effects of theaflavin and synergy with epicatechin against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia. Int J Antimicrob Agents 2011, 38:421-425.
• [13]Suganuma M, Okabe S, Oniyama M, Tada Y, Ito H, Fujiki H: Wide distribution of [3H](−)epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 1998, 19:1771-1776.
• [14]Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB: Bioavailability of Curcumin: Problems and Promises. Mol Pharm 2007, 4(6):807-818.
• [15]Scalbert A, Williamson G: Dietary intake and bioavailability of polyphenols. J Nutr 2000, 130(8):2073S-2085S.
• [16]Sazuka M, Itoi T, Suzuki Y, Odani S, Koide T, Isemura M: Evidence for the interaction between (-)-epigallocatechin gallate and human plasma proteins fibronectin, fibrinogen, and histidine-rich glycoprotein. Biosci Biotechnol Biochem 1996, 60(8):1317-1319.
• [17]Lee MJ, Maliakal P, Chen L, Meng X, Bondoc FY, Prabhu S, Lambert G, Mohr S, Yang CS: Pharmacokinetics of tea catechins after ingestion of green tea and (−)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 2002, 11:1025-1032.
• [18]Aura AM, Martin-Lopez P, O’Leary KA, Williamson G, Oksman-Caldentey KM, Poutanen K, Santos-Buelga C: In vitro metabolism of anthocyanins by human gut microflora. Eur J Nutr 2005, 44(3):133-142.
• [19]Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001, 21(4B):2895-2900.
• [20]Isbrucker RA, Edwards JA, Wolz E, Davidovich A, Bausch J: Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies. Food Chem Toxicol 2006, 44(5):636-650.
• [21]Hornsey M, Phee L, Stubbings W, Wareham DW: In-vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens. Int J Antimicrob Agents 2013, 42(4):343-346.
• [22]Andrews JM: Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001, 49:1049-1050.
• [23]Pillai SK, Moellering RC, Eliopoulos GM: From Antimicrobial combinations. In Antibiotics in Laboratory Medicine. 5th edition. Edited by Lorian V. Lippincott: Williams and Wilkins; 2005:365-440.
• [24]Barry AL, Craig WA, Nadler H, Reller LB, Sanders CC, Swenson JM: From NCCLS: M26-A Approved Guideline Methods for Determining Bactericidal Activity of Antimicrobial Agents. 1999., 19(18) [http://shopping.netsuite.com/c.1253739/site/Sample_pdf/M26A_sample.pdf webcite]
• [25]Bonomo RA, Szabo D: Mechanisms of multidrug-resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis 2006, 43(2):49-56.
• [26]Rai D, Singh JK, Roy N, Panda D: Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity. Biochem J 2008, 410:147-155.
• [27]Odds FC: Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 2003, 52(1):1.
• [28]Milne KE, Gould IM: Combination testing of multidrug-resistant cystic fibrosis isolates of Pseudomonas aeruginosa: use of a new parameter, the susceptibility breakpoint index. J Antimicrob Chemother 2010, 65(1):82-90.
• [29]Shimamura T, Zhao WH, Hu ZQ: Mechanism of action and potential use of tea as an anti-infective agent. Antiinfect Agents Med Chem 2007, 6:57-62.
• [30]Nakagawa H, Hasumi K, Woo JT, Nagai K, Wachi M: Generation of hydrogen peroxide primarily contributes to the induction of Fe(II)-dependent apoptosis in Jurkat cells by (-)-epigallocatechin gallate. Carcinogenesis 2004, 25(9):1567-1574.
• [31]Arakawa H, Maeda M, Okubo S, Shimamura T: Role of hydrogen peroxide in bactericidal action of catechin. Biol Pharm Bull 2004, 27(3):277-281.
• [32]Hatano T, Tsugawa M, Kusuda M, Taniguchi S, Yoshida T, Shiota S, Tsuchiya T: Enhancement of antibacterial effects of epigallocatechin gallate, using ascorbic acid. Phytochem 2008, 69(18):3111-3116.
• [33]Betts JW, Murphy C, Kelly SM, Haswell SJ: Minimum inhibitory and bactericidal concentrations of theaflavin and synergistic combinations with epicatechin and quercetin against clinical isolates of Stenotrophomonas maltophilia. J Microbiol Biotech Food Sci 2012, 1(5):1250-1258.
• [34]Alexander JW, Solomkin JS, Edwards MJ: Updated recommendations for control of surgical site infections. Ann Surg 2011, 253(6):1082-1093.
• [35]Han S, Yang Y: Antimicrobial activity of wool fabric treated with curcumin. Dyes Pigm 2005, 64:157-161.
• [36]Safavy A, Raisch KP, Mantena S, Sanford LL, Sham SW, Krishna R, Bonner JA: Design and development of water-soluble curcumin conjugates as potential anticancer agents. J Med Chem 2009, 50:6284-6288.